Articles avec mandats d'accès public - frederique Penault-llorcaEn savoir plus
Non disponibles : 13
Amphiregulin and epiregulin mRNA expression in primary tumors predicts outcome in metastatic colorectal cancer treated with cetuximab
B Jacobs, W De Roock, H Piessevaux, R Van Oirbeek, B Biesmans, ...
Journal of clinical oncology 27 (30), 5068-5074, 2009
Exigences : Research Foundation (Flanders)
Epigenetic modifications in prostate cancer
M Ngollo, A Dagdemir, S Karsli-Ceppioglu, G Judes, A Pajon, ...
Epigenomics 6 (4), 415-426, 2014
Exigences : Swiss Cancer League
Targeted radionuclide therapy of melanoma: Anti‐tumoural efficacy studies of a new 131I labelled potential agent
M Bonnet‐Duquennoy, J Papon, F Mishellany, P Labarre, ...
International journal of cancer 125 (3), 708-716, 2009
Exigences : Institut national de la santé et de la recherche médicale
Progresses Toward Precision Medicine in RET-altered Solid Tumors
C Belli, S Anand, JF Gainor, F Penault-Llorca, V Subbiah, A Drilon, ...
Clinical Cancer Research 26 (23), 6102-6111, 2020
Exigences : US National Institutes of Health
Vertical VEGF targeting: A combination of ligand blockade with receptor tyrosine kinase inhibition
A Bozec, FX Gros, F Penault-Llorca, P Formento, A Cayre, C Dental, ...
European journal of cancer 44 (13), 1922-1930, 2008
Exigences : Institut national de la santé et de la recherche médicale
In vivo efficacy of melanoma internal radionuclide therapy with a 131I‐labelled melanin‐targeting heteroarylcarboxamide molecule
F Degoul, M Borel, N Jacquemot, S Besse, Y Communal, F Mishellany, ...
International journal of cancer 133 (5), 1042-1053, 2013
Exigences : Institut national de la santé et de la recherche médicale
Loss of glucocorticoid receptor activation is a hallmark of BRCA1-mutated breast tissue
M Vilasco, L Communal, J Hugon-Rodin, F Penault-Llorca, N Mourra, ...
Breast cancer research and treatment 142, 283-296, 2013
Exigences : Institut national de la santé et de la recherche médicale
TIP60: An actor in acetylation of H3K4 and tumor development in breast cancer
G Judes, L Dubois, K Rifaï, M Idrissou, F Mishellany, A Pajon, S Besse, ...
Epigenomics 10 (11), 1415-1430, 2018
Exigences : Swiss Cancer League
Comparative effects of soy phytoestrogens and 17β-estradiol on DNA methylation of a panel of 24 genes in prostate cancer cell lines
M Adjakly, M Ngollo, A Lebert, A Dagdemir, F Penault-Llorca, JP Boiteux, ...
Nutrition and cancer 66 (3), 474-482, 2014
Exigences : Swiss Cancer League
TIP60 inhibitor TH1834 reduces breast cancer progression in xenografts in mice
M Idrissou, G Judes, M Daures, A Sanchez, D El Ouardi, S Besse, ...
OMICS: A Journal of Integrative Biology 23 (9), 457-459, 2019
Exigences : Swiss Cancer League
Epigenetics of prostate cancer: distribution of histone H3K27me3 biomarkers in peri-tumoral tissue
M Ngollo, A Dagdemir, G Judes, JL Kemeny, F Penault-Llorca, JP Boiteux, ...
Omics: a journal of integrative biology 18 (3), 207-209, 2014
Exigences : Swiss Cancer League
Morphological and immunohistochemical pattern of tubo-ovarian dysplasia and serous tubal intraepithelial carcinoma
G Chene, A Cayre, I Raoelfils, N Lagarde, J Dauplat, F Penault-Llorca
European Journal of Obstetrics & Gynecology and Reproductive Biology 183, 89-95, 2014
Exigences : Swiss Cancer League
EZH2 histone methyltransferase and JMJD3 histone demethylase implications in prostate cancer
M Idrissou, M Daures, AB Jemia, G Judes, K Rifaï, F Penault-Llorca, ...
OMICS: A Journal of Integrative Biology 21 (12), 751-753, 2017
Exigences : Swiss Cancer League
Disponibles quelque part : 68
Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013
A Goldhirsch, EP Winer, AS Coates, RD Gelber, M Piccart-Gebhart, ...
Annals of oncology 24 (9), 2206-2223, 2013
Exigences : US National Institutes of Health
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
F Cardoso, S Kyriakides, S Ohno, F Penault-Llorca, P Poortmans, ...
Annals of oncology 30 (8), 1194-1220, 2019
Exigences : US National Institutes of Health
Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working group
M Dowsett, TO Nielsen, R A’Hern, J Bartlett, RC Coombes, J Cuzick, ...
Journal of the National cancer Institute 103 (22), 1656-1664, 2011
Exigences : Cancer Research UK
4th ESO–ESMO international consensus guidelines for advanced breast cancer (ABC 4)
F Cardoso, E Senkus, A Costa, E Papadopoulos, M Aapro, F André, ...
Annals of Oncology 29 (8), 1634, 2019
Exigences : US National Institutes of Health
Cancer cell–autonomous contribution of type I interferon signaling to the efficacy of chemotherapy
A Sistigu, T Yamazaki, E Vacchelli, K Chaba, DP Enot, J Adam, I Vitale, ...
Nature medicine 20 (11), 1301-1309, 2014
Exigences : National Health and Medical Research Council, Australia, German Research …
3rd ESO–ESMO international consensus guidelines for advanced breast cancer (ABC 3)
F Cardoso, A Costa, E Senkus, M Aapro, F André, CH Barrios, J Bergh, ...
The Breast 31, 244-259, 2017
Exigences : US National Institutes of Health
Analysis of PTEN, BRAF, and EGFR Status in Determining Benefit From Cetuximab Therapy in Wild-Type KRAS Metastatic Colon Cancer
P Laurent-Puig, A Cayre, G Manceau, E Buc, JB Bachet, T Lecomte, ...
Journal of clinical oncology 27 (35), 5924-5930, 2009
Exigences : Institut national de la santé et de la recherche médicale
Les informations concernant la publication et le financement sont déterminées automatiquement par un programme informatique